If you are a member of the SGNA and have selected Chesapeake SGNA as your region, you should received a ballot. The ballot is on the Chesapeake SGNA and Delaware SGNA merging into a new SGNA Region. Only those from the Chesapeake Region membership list on the SGNA website will be allowed to vote. Please do not forget to write your SGNA number on your ballot. Check your junk email. Contact: [email protected] if you did not received a ballot.
The Chesapeake Society of Gastroenterology Nurses and Associates
The Chesapeake Society of Gastroenterology Nurses and Associates is affiliated with the National Society of Gastroenterology Nurses and Associates (SGNA). CSGNA is a group of professional nurses and associates of various backgrounds whose goal is to provide optimal care to patients seeking treatment for gastrointestinal disorders. Gastrointestinal (GI) Nurses and Associates practice in hospitals, ambulatory endoscopy centers, and physician offices. We strive to enhance our own clinical knowledge through educational programs incorporating new concepts in an ever-changing technology.
The CSGNA is looking for enthusiastic members in making our Society the best that it can be.
Latest GI News
- Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017Trends of mortality associated with extrahepatic complications of chronic liver disease might be changing. We studied trends in mortality from extrahepatic complications of viral hepatitis, alcoholic liver disease (ALD), and nonalcoholic fatty liver disease in the United States. ... read more
- Gastroenterologist-Level Identification of Small-Bowel Diseases and Normal Variants by Capsule Endoscopy Using a Deep-Learning ModelCapsule endoscopy has revolutionized investigation of the small bowel. However, this technique produces a video that is 8–10 hours long, so analysis is time consuming for gastroenterologists. Deep convolutional neural networks (CNNs) can recognize specific images among a large variety. We aimed to develop a CNN-based algorithm to assist in the evaluation of small bowel capsule endoscopy (SB-CE) images. ... read more
- Will Science Sway Beliefs About Gluten?For years, gluten has been a rich source of controversy. It has been blamed for its contribution to symptoms and to disease development and progression without much data supporting this premise, except in the case of celiac disease. Mostly celebrity- and media-led endorsements for a gluten-free diet (GFD) have fueled the idea that a GFD is a healthy diet rather than a therapeutic one, and media messages fail to highlight ... read more
- Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary CancerBile duct tumors are rare and have poor prognoses. Natural killer (NK) cells are frequent in human liver and infiltrate these tumors but do not control their progression. Responses of NK cells are regulated by NK immunoglobulin-like receptors (KIRs), which interact with HLA class I ligands. We aimed to characterize the features of the KIR gene loci and their ligands in patients with bile duct cancer (BDC). ... read more
- Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Workshop to Identify Barriers and Move Forward
- Superficially deceiving gastric lesion – what lies beneath?
- Accurate and Dynamic Monitoring of Pancreatic Endocrine Function Is Required in Discharged Patients With Necrotizing PancreatitisWe read with great interest the recently published study on the long-term follow-up of patients with necrotizing pancreatitis reported by Hollemans et al.1 It is an elegantly conducted study comparing the clinical outcomes between surgical step-up approach and open necrosectomy for an average of 7 years of follow-up. However, some potential biases need to be addressed. ... read more
- Treatment of Active Crohn’s Disease With an Ordinary Food-Based Diet That Replicates Exclusive Enteral NutritionWe read with great enthusiasm the article by Svolos et al1 reporting the response of active Crohn’s disease (CD) to a specific ordinary food-based diet, the CD-TREAT diet. The authors present layered data from a rat model, longitudinal human study, and small-scale clinical outcomes. Experimental data from the adult volunteers showed evidence for similar microbial changes in the CD-TREAT diet to those seen in exclusive enteral nutrition (EEN). There was a ... read more
- Improving Clinical Trial Efficiency in GastroenterologyWe read with interest the recent article by Harris and Howden, “Innovative Trial Designs in GI Drug Development: Why Trials Succeed and Fail,”1 Given the rich pipeline of next-generation therapies across multiple disciplines of gastroenterology, we are pleased to see this dialogue on critical, although often neglected topics, in clinical trial design. Many agents that seem to be promising in preclinical studies fail to show efficacy in human trials, and ... read more
- Future Possibility of Mizagliflozin on Functional Constipation and/or Irritable Bowel Syndrome With ConstipationWe read the recent Selected Summary by Black and Ford1 on our article of the efficacy of mizagliflozin on functional constipation.2 We appreciate their interest on our article and would like to respond to their comments. Black and Ford described physicians’ difficulty in selecting new pharmacologic agents for chronic idiopathic constipation, including lubiprostone, linaclotide, plecanatide, elobixibat, and prucalopride.1 They concluded that the effects of these agents are comparative and that ... read more